IRIDEX Corporation (IRIX)

Market Cap	17.29M
Revenue (ttm)	48.80M
Net Income (ttm)	-7.13M
Shares Out	16.79M
EPS (ttm)	-0.43
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	44,495
Open	0.996
Previous Close	1.000
Day's Range	0.996 - 1.030
52-Week Range	0.782 - 2.408
Beta	0.57
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2025

About IRIX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retino...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 15, 1996
• Employees: 93
• Stock Exchange: NASDAQ
• Ticker Symbol: IRIX
• Website: https://www.iridex.com

Financial Performance

In 2024, IRIDEX's revenue was $48.67 million, a decrease of -6.17% compared to the previous year's $51.87 million. Losses were -$8.91 million, -6.90% less than in 2023.